These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 16484873

  • 1. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
    Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL.
    J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
    [Abstract] [Full Text] [Related]

  • 2. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus.
    Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL.
    Cardiology; 2007 Feb; 108(4):331-7. PubMed ID: 17299260
    [Abstract] [Full Text] [Related]

  • 3. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
    Emmer BJ, Steup-Beekman GM, Steens SC, Huizinga TW, van Buchem MA, van der Grond J.
    Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847
    [Abstract] [Full Text] [Related]

  • 4. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
    Sibbitt WL, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM.
    J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
    [Abstract] [Full Text] [Related]

  • 5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
    Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR.
    J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
    [Abstract] [Full Text] [Related]

  • 7. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
    Sibbitt WL, Schmidt PJ, Hart BL, Brooks WM.
    J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
    [Abstract] [Full Text] [Related]

  • 8. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
    Ainiala H, Dastidar P, Loukkola J, Lehtimäki T, Korpela M, Peltola J, Hietaharju A.
    Scand J Rheumatol; 2005 Sep; 34(5):376-82. PubMed ID: 16234185
    [Abstract] [Full Text] [Related]

  • 9. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimäki T, Peltola J, Korpela M, Heinonen T, Nikkari ST.
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [Abstract] [Full Text] [Related]

  • 10. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA.
    Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
    [Abstract] [Full Text] [Related]

  • 11. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Jan; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 12. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Kimura A, Kanoh Y, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Takemura M, Seishima M, Inuzuka T.
    Neurology; 2010 Apr 27; 74(17):1372-9. PubMed ID: 20421581
    [Abstract] [Full Text] [Related]

  • 13. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain.
    Hughes M, Sundgren PC, Fan X, Foerster B, Nan B, Welsh RC, Williamson JA, Attwood J, Maly PV, Chenevert TL, McCune W, Gebarski S.
    Acta Radiol; 2007 Mar 27; 48(2):213-22. PubMed ID: 17354144
    [Abstract] [Full Text] [Related]

  • 14. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan 27; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 15. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging.
    Bosma GP, Rood MJ, Huizinga TW, de Jong BA, Bollen EL, van Buchem MA.
    Arthritis Rheum; 2000 Nov 27; 43(11):2428-36. PubMed ID: 11083265
    [Abstract] [Full Text] [Related]

  • 16. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE, Koutroumanidis M, Reynolds PP, Manidakis I, Hughes GR, D'Cruz DP.
    Arthritis Rheum; 2005 Mar 27; 52(3):841-6. PubMed ID: 15751063
    [Abstract] [Full Text] [Related]

  • 17. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM.
    Arch Intern Med; 2006 Nov 13; 166(20):2278-84. PubMed ID: 17101948
    [Abstract] [Full Text] [Related]

  • 18. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J.
    World J Biol Psychiatry; 2010 Mar 13; 11(2):121-8. PubMed ID: 20109107
    [Abstract] [Full Text] [Related]

  • 19. Libman-Sacks endocarditis and embolic cerebrovascular disease.
    Roldan CA, Sibbitt WL, Qualls CR, Jung RE, Greene ER, Gasparovic CM, Hayek RA, Charlton GA, Crookston K.
    JACC Cardiovasc Imaging; 2013 Sep 13; 6(9):973-83. PubMed ID: 24029368
    [Abstract] [Full Text] [Related]

  • 20. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY, Tam LS, Lee VW, Lee KK, Li EK.
    Rheumatology (Oxford); 2009 May 13; 48(5):564-8. PubMed ID: 19269959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.